source
- Roche halts development of muscle-preserving obesity drug and returns program to ChugaiRoche announced it is ending work on the experimental muscle-building compound known as GYM329, which had been tested together with a GLP-1 based anti-obesity injection. The decision stops the ong…
- Regenerative medicine requires diagnostics and product characterization beyond stem cell basicsStem cell therapies are often portrayed as a single treatment, but they actually vary widely in tissue source, cell passage, viability and delivery methods. Experts say a credible regenerative app…